Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $80.46 | $24.27 | 231.49% | 151.81x | 38.67x | 10.21x | 12.32x | 1.11x | $106.92M | 1.26% | $705.78M | 6.70 | $8.60B | 1,095.73 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $31.26 | $8.38 | 273.25% | 148.86x | 71.73x | 8.79x | 17.81x | 1.27x | $39.15M | 0.96% | $220.58M | 1.69 | $4.01B | 88.31 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $307.02 | $74.80 | 310.44% | 115.86x | 31.96x | 24.14x | 6.39x | 1.48x | $90.43M | 1.48% | $961.76M | 48.18 | $7.24B | 73.50 | ||
| HALO | HALOZYME THERAPEUTICS INC | $128.95 | $72.10 | 78.86% | 36.22x | 14.31x | 9.09x | 101.96x | 0.70x | $806.22M | 5.33% | $143.54M | 1.22 | $16.62B | 23.13 | ||
| RPRX | ROYALTY PHARMA PLC | $66.52 | $37.12 | 79.22% | 35.38x | 12.26x | 11.67x | 3.91x | 0.71x | $2.92B | 9.88% | $9.79B | 21.99 | $46.40B | 39.45 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.44 | $19.82 | 189.77% | 151.16x | 25.97x | 3.26x | 1.76x | 0.96x | $738.18M | 6.64% | $6.32B | 32.68 | $14.43B | 37.42 | ||
| VCEL | VERICEL CORP | $40.51 | $8.15 | 397.19% | 84.40x | 71.88x | 6.76x | 5.61x | 2.07x | $61.66M | 2.98% | $370.04M | 7.25 | $2.04B | 46.35 | ||
| KRYS | KRYSTAL BIOTECH INC | $295.90 | $76.60 | 286.30% | 35.78x | 39.45x | 19.84x | 6.44x | 2.37x | $257.78M | 2.95% | $1.36B | 46.03 | $8.34B | 35.75 | ||
| ADMA | ADMA BIOLOGICS INC | $11.06 | $7.11 | 55.61% | 15.36x | 13.90x | 4.93x | 6.07x | 0.90x | $116.47M | 4.61% | $408.21M | 1.79 | $2.54B | 10.90 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $90.80 | $14.70 | 517.61% | 63.50x | 69.95x | 7.51x | 10.05x | 3.43x | $197.20M | 2.78% | $710.19M | 9.08 | $7.06B | 46.44 | ||
| TGTX | TG THERAPEUTICS INC | $59.95 | $22.83 | 162.65% | 19.46x | 58.48x | 10.63x | 15.19x | 2.17x | $17.39M | 0.21% | $604.08M | 4.26 | $9.45B | 67.85 | ||
| EXEL | EXELIXIS INC | $70.13 | $32.09 | 118.55% | 20.33x | 20.34x | 6.93x | 9.33x | 1.33x | $1.16B | 6.71% | $1.83B | 7.43 | $16.97B | 15.19 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $214.44 | $191.36 | 12.06% | 14.05x | 14.18x | 2.95x | 2.90x | 0.54x | $1.62B | 11.95% | $4.80B | 75.98 | $16.70B | 10.33 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $553.15 | $150.75 | 266.94% | 31.92x | 28.87x | 11.15x | 6.92x | 2.41x | $3.80B | 2.71% | $20.25B | 79.81 | $136.04B | 24.72 | ||
| INCY | INCYTE CORP | $120.04 | $54.09 | 121.91% | 57.44x | 35.77x | 4.06x | 4.34x | 0.82x | $684.87M | 2.81% | $5.64B | 27.76 | $21.22B | 23.66 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.10 | $7.75 | 30.28% | 10.63x | 9.28x | 4.39x | 2.76x | 0.93x | $82.01M | 13.72% | $217.65M | 3.68 | $455.95M | 5.90 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.91 | $31.62 | 19.89% | 12.07x | 9.15x | 2.29x | 2.21x | 0.68x | $354.90M | 16.16% | $999.24M | 17.25 | $1.81B | 6.47 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $961.26 | $462.91 | 107.66% | 20.45x | 14.94x | 5.79x | 2.97x | 1.20x | $3.83B | 3.91% | $33.50B | 329.39 | $98.49B | 15.77 | ||
| TECH | BIO-TECHNE CORP | $72.67 | $16.61 | 337.57% | 62.11x | 34.98x | 9.33x | 5.41x | 1.97x | $263.22M | 2.32% | $2.11B | 13.52 | $11.42B | 32.85 | ||
| UTHR | UNITED THERAPEUTICS CORP | $596.13 | $207.04 | 187.93% | 19.71x | 21.86x | 8.05x | 3.99x | 2.78x | $1.09B | 4.30% | $6.40B | 150.24 | $23.77B | 14.18 | ||
| VCYT | VERACYTE INC | $49.00 | $12.14 | 303.60% | 34.03x | 25.26x | 6.97x | 2.84x | 2.75x | $165.99M | 4.24% | $1.39B | 17.36 | $3.68B | 26.33 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.